NR

Nidhi Rajput

Active Director Director DIN 07798082
DIN 07798082 First appointment Sep 2017 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Nidhi Rajput

Data last updated:

Nidhi Rajput is a Director at Akromed Pharmaceuticals (Opc) Private Limited (since 2017). The company operates in Chemicals. Akromed Pharmaceuticals (Opc) Private Limited reported revenue of ₹3.1 Lakh (FY 2025).

DIN 07798082
Primary Designation Director
Industry Chemicals
First Appointment 25 Sep 2017
Oldest Company Age 9 yrs
Largest company Akromed Pharmaceuticals (Opc) Private Limited · ₹3.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Sep 20172017₹3.1 Lakh (FY 2025)Active

Board colleagues of Nidhi Rajput

Directorship timeline

Open interactive timeline →
Akromed Pharmaceuticals (Opc) Private Limited
Premium access

Shareholding and investment profile for Nidhi Rajput

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nidhi Rajput

Nidhi Rajput currently holds 1 directorship: Akromed Pharmaceuticals (Opc) Private Limited (Director, since 25 Sep 2017, revenue ₹3.1 Lakh (FY 2025)).

Nidhi Rajput was first appointed on 25 Sep 2017 as Director at Akromed Pharmaceuticals (Opc) Private Limited.

The current boards of Nidhi Rajput's companies include Abhishek Singh Rajput (Akromed Pharmaceuticals (Opc) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available